Levels and trends of metals in human populations living in the Arctic.


Journal

International journal of circumpolar health
ISSN: 2242-3982
Titre abrégé: Int J Circumpolar Health
Pays: United States
ID NLM: 9713056

Informations de publication

Date de publication:
Dec 2024
Historique:
medline: 22 8 2024
pubmed: 22 8 2024
entrez: 22 8 2024
Statut: ppublish

Résumé

The 2021 Arctic Monitoring Assessment Program (AMAP)'s Human Health Assessment report presents a summary of the presence of contaminants in human populations across the circumpolar Arctic and provides an update to the previous assessment released in 2015. The primary objective of this paper is to summarise some of these findings by describing the current levels of metals across the Arctic, including key regional and temporal trends based on available national data and literature, and highlight knowledge gaps. Many Arctic populations continue to have elevated levels of these contaminants, and the highest levels of mercury (Hg) were observed in populations from Greenland, Faroe Islands, and Nunavik (Canada). Still, concentrations of several metals are declining in Arctic populations in regions where time trends data exist, although the declines are not consistent across all regions. The 2021 AMAP human health assessment report and this paper provide an extensive summary of levels of metals and trace elements in adults, pregnant women, and children across the Arctic.

Identifiants

pubmed: 39169885
doi: 10.1080/22423982.2024.2386140
doi:

Substances chimiques

Metals 0
Environmental Pollutants 0
Mercury FXS1BY2PGL

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2386140

Auteurs

Bryan Adlard (B)

Environmental Health Science and Research Bureau, Health Canada, Ottawa, Canada.

Eva C Bonefeld-Jørgensen (EC)

Centre for Arctic Health & Molecular Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.
Greenland Center for Health Research, University of Greenland, Nuussuaq, Greenland.

Alexey A Dudarev (AA)

Arctic Environmental Health Department, Northwest Public Health Research Center, St-Petersburg, Russia.

Kristin Olafsdottir (K)

Department of Pharmacology & Toxicology, University of Iceland, Reykjavik, Iceland.

Khaled Abass (K)

Department of Environmental Health Sciences, College of Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.
Biomedicine and Internal Medicine, Faculty of Medicine University of Oulu, Finland.

Pierre Ayotte (P)

Département de médecine sociale et préventive, Centre de recherche du CHU de Québec-Université Laval and INSPQ, Québec City, Canada.

Élyse Caron-Beaudoin (É)

Deptartment of Health and Society, University of Toronto Scarborough, Scarborough, ON, Canada.

Mallory Drysdale (M)

School of Public Health Sciences, University of Waterloo, Waterloo, Canada.

Joshua Garcia-Barrios (J)

School of Public Health Sciences, University of Waterloo, Waterloo, Canada.

Irina Gyllenhammar (I)

Swedish Food Agency, Deptartment of Risk & Benefit Assessment, Uppsala, Sweden.

Brian Laird (B)

School of Public Health Sciences, University of Waterloo, Waterloo, Canada.

Melanie Lemire (M)

Centre de recherche du CHU de Québec-Université Laval; Département de médecine sociale et préventive, Institut de biologie intégrative et des systèmes, Université Laval, Québec City, Canada.

Sanna Lignell (S)

Swedish Food Agency, Deptartment of Risk & Benefit Assessment, Uppsala, Sweden.

Manhai Long (M)

Centre for Arctic Health & Molecular Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.

Karin Norström (K)

Swedish Environmental Protection Agency, Stockholm, Sweden.

Sara Packull-McCormick (S)

School of Public Health Sciences, University of Waterloo, Waterloo, Canada.

Maria Skaalum Petersen (MS)

Department of Research, National Hospital of the Faroe Islands, Torshavn, Faroe Islands.

Mylene Ratelle (M)

School of Public Health, University of Montreal, Montreal, Québec, Canada.

Arja Rautio (A)

Biomedicine and Internal Medicine, Faculty of Medicine University of Oulu, Finland.

Amalie Timmerman (A)

National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark.

Pal Weihe (P)

Department of Research, National Hospital of the Faroe Islands, Torshavn, Faroe Islands.

Maria Wennberg (M)

Section of Sustainable Health, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH